Literature DB >> 7386528

Direct radioimmunoassay of urinary estrogen and pregnanediol glucuronides during the menstrual cycle.

F Z Stanczyk, I Miyakawa, U Goebelsmann.   

Abstract

Entities:  

Keywords:  Biology; Endocrine System; Estradiol--analysis; Estriol--analysis; Estrogens; Examinations And Diagnoses; Gonadotropins; Gonadotropins, Pituitary; Hormones; Laboratory Examinations And Diagnoses; Laboratory Procedures; Luteinizing Hormone--analysis; Menstrual Cycle; Menstruation; Ovulation Detection; Physiology; Progestational Hormones; Progesterone--analysis; Reproduction

Mesh：

Substances：

Year:  1980        PMID： 7386528     DOI： 10.1016/0002-9378(80)91125-4

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN： 0002-9378            Impact factor:   8.661


× No keyword cloud information.
  17 in total

1.  Comparability of serum, plasma, and urinary estrogen and estrogen metabolite measurements by sex and menopausal status.

Authors:  Sally B Coburn; Frank Z Stanczyk; Roni T Falk; Katherine A McGlynn; Louise A Brinton; Joshua Sampson; Gary Bradwin; Xia Xu; Britton Trabert
Journal:  Cancer Causes Control       Date:  2018-12-01       Impact factor: 2.506

2.  Sleep symptoms during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study.

Authors:  Nancy Fugate Woods; Ellen Sullivan Mitchell
Journal:  Sleep       Date:  2010-04       Impact factor: 5.849

3.  Characterization of luteal function by measuring the cumulative concentration of serum progesterone and urine pregnanediol-3 alpha-monoglucuronide.

Authors:  G Aprò; G Falkay; M Sas
Journal:  J Endocrinol Invest       Date:  1983-06       Impact factor: 4.256

4.  Endocrine biomarkers and symptom clusters during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study.

Authors:  Nancy Fugate Woods; Lori Cray; Ellen Sullivan Mitchell; Jerald R Herting
Journal:  Menopause       Date:  2014-06       Impact factor: 2.953

5.  Association of estrogen measurements in serum and urine of premenopausal women.

Authors:  Gertraud Maskarinec; Fanchon Beckford; Yukiko Morimoto; Adrian A Franke; Frank Z Stanczyk
Journal:  Biomark Med       Date:  2015       Impact factor: 2.851

6.  Cortisol levels during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study.

Authors:  Nancy Fugate Woods; Ellen Sullivan Mitchell; Kathleen Smith-Dijulio
Journal:  Menopause       Date:  2009 Jul-Aug       Impact factor: 2.953

7.  Select steroid hormone glucuronide metabolites can cause toll-like receptor 4 activation and enhanced pain.

Authors:  Susannah S Lewis; Mark R Hutchinson; Morin M Frick; Yingning Zhang; Steven F Maier; Tarek Sammakia; Kenner C Rice; Linda R Watkins
Journal:  Brain Behav Immun       Date:  2014-09-16       Impact factor: 7.217

8.  Constipation and diarrhea during the menopause transition and early postmenopause: observations from the Seattle Midlife Women's Health Study.

Authors:  Nini G L Callan; Ellen S Mitchell; Margaret M Heitkemper; Nancy F Woods
Journal:  Menopause       Date:  2018-06       Impact factor: 2.953

9.  Hormonal Profiles of Menstrual Bleeding Patterns During the Luteal-Follicular Transition.

Authors:  Melanie H Jacobson; Penelope P Howards; James S Kesner; Juliana W Meadows; Celia E Dominguez; Jessica B Spencer; Lyndsey A Darrow; Metrecia L Terrell; Michele Marcus
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

10.  Is the menopausal transition stressful? Observations of perceived stress from the Seattle Midlife Women's Health Study.

Authors:  Nancy Fugate Woods; Ellen Sullivan Mitchell; Don B Percival; Kathleen Smith-DiJulio
Journal:  Menopause       Date:  2009 Jan-Feb       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.